Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

PDX bank from urothelial cancer to guide precision medicine.

ABSTRACT: PDX bank from urothelial cancer to guide precision medicine.

PROVIDER: PRJNA754098 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

PDX bank from urothelial cancer to guide precision medicine.

Project description:We developed preclinical PDX models, recapitulating the molecular heterogeneity of MIBCs and UTUC, which will represent an essential tool in therapy development. Pharmacological characterization of the PDXs suggested that upper urinary tract and bladder cancers (UCC/ SCC) with similar molecular characteristics could benefit from the same treatments, and showed a benefit for combined FGFR/EGFR inhibition in FGFR3-mutant PDXs, compared to FGFR inhibition alone.

2022-08-31 | GSE181962 | GEO

Patient-Derived Xenografts of Upper Tract Urothelial Cell Carcinoma: a tool for precision medicine

Project description:Treatment paradigms for patients with upper tract urothelial carcinoma (UTUC) are typically extrapolated from studies of bladder cancer despite their distinct clinical and molecular characteristics. A major hurdle to the advancement of UTUC research is the lack of disease-specific models. Here, we report the establishment of patient derived xenograft (PDX) and cell lines models that reflect the heterogeneity of the human disease. Models demonstrated high genomic concordance with the tumors from which they were derived with muscle-invasive tumors more likely to successfully engraft. Treatment of PDX with chemotherapy recapitulated responses observed in the patients. Analysis of a S310F HER2 mutant PDX suggested that an antibody drug conjugate targeting HER2 would have superior efficacy to HER2-selective kinase inhibitors. In sum, the biologic and phenotypic concordance between patient and PDXs suggests that these models could facilitate studies of intrinsic and acquired resistance and the development of personalized medicine strategies for UTUC patients.

2020-01-29 | GSE134292 | GEO

Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer

Project description:Developing animal models representating the cancer biology of advanced prostate cancer patients is challenging but essential for delivering individualized medical therapies. In an effort to develop patient derived xenograft (PDX) models, we took the metastatic site tissue from the rib lesion twice (ie, before and after enzalutamide treatment) over a twelve week period and implanted subcutaneously and under the renal capsule in immuno-deficient mice. To characterize and compare the genome and transcriptome landscapes of patient tumor tissues and the corresponding PDX models, we performed whole exome and transcriptome sequencing for metastatic tumor tissue as well as its derived PDXs. We demonstrated the feasibility of developping PDX models from patient who developed castrate-resistant prostate cancer. Our data suggested PDX models preserve the patient’s genomic and transcriptomic alterations in high fidelity, as illustrated by somatic mutation, copy number variation, gene fusion and gene expression. RNA sequencing of prostate cancer tumor tissue and derived xenograft using Illumina HiSeq 2000.

2015-06-30 | E-GEOD-70380 | biostudies-arrayexpress

RNA-seq profiling of patient-derived xenograft models in Urothelial Cancer

Project description:To probe the tissue source (cancer cell VS stromal cell) of gene expression in the mixed tumor samples, we took advantage of a set of Urothelial Cancer patient-derived xenograft (PDX) models given that the transcriptome in these models is a mixture of human RNA (derived from cancer cells) and mouse RNA (derived from stromal cells).

2018-08-01 | GSE116159 | GEO

Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer

2015-06-30 | GSE70380 | GEO

Precision Medicine to Treat Urothelial Carcinoma-The Way Forward.

Project description: Not available

| S-EPMC10252480 | biostudies-literature

Characteristics PDX

Project description:Characteristics PDX

| PRJEB74764 | ENA

Patient-Derived Xenografts of Upper Tract Urothelial Cell Carcinoma: a tool for precision medicine

Project description:Patient-Derived Xenografts of Upper Tract Urothelial Cell Carcinoma: a tool for precision medicine

| PRJNA554654 | ENA

Characterization of gene expression in canine invasive urothelial carcinoma using a NanoString-based urine assay

Project description:For human and canine invasive urothelial carcinoma (InvUC), there is growing interest in using the molecular characteristics of a tumor to guide individualized treatment strategies. The objective of this study was to use a noninvasive, urine-based method to characterize gene expression signatures in dogs with InvUC.

2026-01-20 | GSE279551 | GEO

Unlocking Overexpressed Membrane Proteins to Guide Breast Cancer Precision Medicine.

Project description: Not available

| S-EPMC11011122 | biostudies-literature